Conceptually similarSCIMATGefitinib Molecular ModelSS2541719BW9463SCIMATGefitinib molecular modelSS2541720BW9464SCIMATGefitinib molecular modelSS2541721BW9465SCIMATGefitinib molecular modelSS2541723BW9467SPL RF ImagesGefinitib cancer drug moleculeSS21210973SPL RF ImagesGefinitib cancer drug moleculeSS21210974SPL RF ImagesGefinitib cancer drug moleculeSS21210975SPL RF ImagesGefinitib cancer drug moleculeSS21210976SPL RF ImagesVandetanib cancer drug moleculeSS21252586View AllView more with similar tones Gefitinib molecular modelLicense type:Rights ManagedUnique identifier:SS2541722Legacy Identifier:BW9466Description:Molecular model of gefitinib. Gefitinib is a new medicine; a selective inhibitor of the epidermal growth factor receptor's (EGFR) tyrosine kinase domain. It binds to the adenosine triphosphate (ATP) binding site of the enzyme and in this way inhibits the growth of malignant cells. C22 H24 Cl F N4 O3. Carbon in grey; Hydrogen in yellow; Nitrogen in orange; Chlorine in green; Fluorine in red; Oxygen in blue.Credit:Scimat/Science SourceSize:3060px × 1908px (~16 MB)Get PricingHow Will The Visual Be Used?ShareKeywords:astrazeneca-atp-carbon-chemistry-chlorine-drug-egfr-epidermal growth factor receptor-fluorine-gefitinib-hydrogen-inhibitor of cell growth-iressa-medicine-molecular-molecular model-molecular modeling-molecule model-molecules-nitrogen-oxygen-selective inhibitor-teva-treatment-tyrosine kinaseModel release:N/AParent folder:17249
